Long-Term Reduction of C-Reactive Protein by LDL Apheresis
October 2002
in “
Atherosclerosis Supplements
”
TLDR LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.
The study investigated the long-term effects of LDL apheresis on C-reactive protein (CRP) levels, which are markers of inflammation and cardiovascular risk. The research demonstrated that LDL apheresis, a procedure used to lower LDL cholesterol levels, also resulted in a significant reduction in CRP levels over an extended period. This finding suggested that LDL apheresis could have additional benefits beyond cholesterol reduction, potentially lowering inflammation and associated cardiovascular risks. The study provided evidence supporting the use of LDL apheresis as a therapeutic approach for patients with high cardiovascular risk due to elevated LDL cholesterol and CRP levels.
